Encompass Health Corporation (NYSE:EHC – Get Free Report) has been given an average recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $144.1667.
EHC has been the topic of several recent research reports. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays cut their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th.
View Our Latest Stock Analysis on EHC
Insider Buying and Selling at Encompass Health
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. Arkadios Wealth Advisors raised its position in Encompass Health by 9.4% during the 1st quarter. Arkadios Wealth Advisors now owns 12,797 shares of the company’s stock worth $1,238,000 after purchasing an additional 1,102 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Encompass Health by 11.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,757 shares of the company’s stock worth $557,000 after acquiring an additional 585 shares in the last quarter. California State Teachers Retirement System raised its position in shares of Encompass Health by 23.5% in the 1st quarter. California State Teachers Retirement System now owns 117,714 shares of the company’s stock worth $11,386,000 after acquiring an additional 22,368 shares in the last quarter. Eversept Partners LP raised its position in shares of Encompass Health by 81.5% in the 1st quarter. Eversept Partners LP now owns 194,104 shares of the company’s stock worth $18,776,000 after acquiring an additional 87,178 shares in the last quarter. Finally, Lazard Asset Management LLC raised its position in shares of Encompass Health by 34.5% in the 1st quarter. Lazard Asset Management LLC now owns 98,693 shares of the company’s stock worth $9,547,000 after acquiring an additional 25,335 shares in the last quarter. 97.25% of the stock is owned by institutional investors.
Encompass Health Trading Down 1.2%
Shares of EHC stock opened at $104.82 on Friday. The stock’s fifty day moving average price is $102.87 and its two-hundred day moving average price is $105.97. The company has a market cap of $10.40 billion, a PE ratio of 17.50, a P/E/G ratio of 2.31 and a beta of 0.72. Encompass Health has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17.
Encompass Health (NYSE:EHC – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities analysts predict that Encompass Health will post 5.96 EPS for the current fiscal year.
Encompass Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.69%.
About Encompass Health
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Read More
- Five stocks we like better than Encompass Health
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
